Insmed, Inc. (NASDAQ:INSM)

CAPS Rating: 4 out of 5

Insmed Incorporated, a biopharmaceutical company, is focused on developing and commercializing novel, targeted inhalation therapies.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 10/2/2012 8:22:22 PM : Outperform Start Price: $4.85 INSM Score: +38.84

FDA action may keep the positive momentum going

Report this Post Reply

Featured Broker Partners


Advertisement